|
Biorestorative Therapies Inc (NASDAQ: BRTX) |
|
Biorestorative Therapies Inc
BRTX's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Biorestorative Therapies Inc growth rates, revenue grew
by 262.17 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2403
Healthcare Facilities industry recorded
growth of revenues by 7.33 %
Biorestorative Therapies Inc net loss decreased from $-3 millions, to $-1 millions in III. Quarter 2024,
• More on BRTX's Growth
|
|
Biorestorative Therapies Inc realized a net loss in trailing twelve months.
Biorestorative Therapies Inc realized cash reduction of $ -0.04 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 50.83.
Healthcare Facilities industry's Price to Sales ratio is at 1.09.
• More on BRTX's Valuation
|
|
|
|
|
Biorestorative Therapies Inc realized net loss in trailing twelve months.
Biorestorative Therapies Inc realized cash outflow of $ -0.04per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 50.83.
Healthcare Facilities industry's Price to Sales ratio is at 1.09.
Biorestorative Therapies Inc Price to Book Ratio is at 1.93 lower than Industry Avg. of 181.24. and higher than S&P 500 Avg. of 0.01
• More on BRTX's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com